148 related articles for article (PubMed ID: 35571196)
1. Long-Term Clinical Outcomes Between Biodegradable and Durable Polymer Drug-Eluting Stents: A Nationwide Cohort Study.
Lee SJ; Choi DW; Suh Y; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Park EC; Jang Y; Nam CM; Hong MK
Front Cardiovasc Med; 2022; 9():873114. PubMed ID: 35571196
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial Infarction.
Choe JC; Cha KS; Lee JG; Kim J; Shin JY; Ahn J; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Jeong MH;
JACC Cardiovasc Interv; 2020 Jan; 13(1):97-111. PubMed ID: 31918948
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction.
Sim HW; Thong EH; Djohan AH; Chen JZ; Ser JS; Loh PH; Lee CH; Chan MY; Low AF; Tay EL; Chan KH; Tan HC; Loh JP
Cardiovasc Revasc Med; 2022 Feb; 35():98-103. PubMed ID: 33893053
[TBL] [Abstract][Full Text] [Related]
4. One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Atherosclerosis; 2019 May; 284():102-109. PubMed ID: 30877937
[TBL] [Abstract][Full Text] [Related]
5. Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
PLoS One; 2018; 13(10):e0205046. PubMed ID: 30289945
[TBL] [Abstract][Full Text] [Related]
6. Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials.
Cassese S; Xhepa E; Ndrepepa G; Kufner S; Colleran R; Giacoppo D; Koppara T; Mankerious N; Byrne RA; Laugwitz KL; Schunkert H; Fusaro M; Kastrati A; Joner M
Eur Heart J Cardiovasc Imaging; 2018 Nov; 19(11):1294-1301. PubMed ID: 29300853
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Acute Myocardial Infarction Patients Implanted With Biodegradable Polymer Biolimus-Eluting Stents Versus New-Generation Durable Polymer Drug-Eluting Stents: A Retrospective Analysis.
Choe JC; Cha KS; Jang HY; Choi JH; Kim BW; Ahn J; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Ahn Y; Jeong MH;
Angiology; 2017 Sep; 68(8):698-706. PubMed ID: 27872316
[TBL] [Abstract][Full Text] [Related]
8. Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Heart Vessels; 2019 Feb; 34(2):237-250. PubMed ID: 30167772
[TBL] [Abstract][Full Text] [Related]
9. Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).
Hur SH; Kim IC; Won KB; Cho YK; Yoon HJ; Nam CW; Kim KB; Kim MS; Park J; Rha SW; Chae SC; Kim YJ; Kim CJ; Cho MC; Jeong MH; Ahn YK; Kim HS; Ahn TH; Seung KB; Jang Y; Yoon JH; Seong IW; Hong TJ; Bae JH; Park SJ;
Clin Cardiol; 2016 May; 39(5):276-84. PubMed ID: 27028303
[TBL] [Abstract][Full Text] [Related]
10. Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents.
El-Hayek G; Bangalore S; Casso Dominguez A; Devireddy C; Jaber W; Kumar G; Mavromatis K; Tamis-Holland J; Samady H
JACC Cardiovasc Interv; 2017 Mar; 10(5):462-473. PubMed ID: 28279314
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Durable-Polymer- and Biodegradable-Polymer-Based Newer-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes After Successful Percutaneous Coronary Intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Int Heart J; 2020 Jul; 61(4):673-684. PubMed ID: 32684595
[TBL] [Abstract][Full Text] [Related]
12. Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
Iglesias JF; Muller O; Losdat S; Roffi M; Kurz DJ; Weilenmann D; Kaiser C; Heg D; Valgimigli M; Windecker S; Pilgrim T
Int J Cardiol; 2021 Jul; 334():37-41. PubMed ID: 33887341
[TBL] [Abstract][Full Text] [Related]
13. Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
Kim HS; Kang J; Hwang D; Han JK; Yang HM; Kang HJ; Koo BK; Kim SY; Park KH; Rha SW; Shin WY; Lim HS; Park K; Park KW;
Circulation; 2021 Mar; 143(11):1081-1091. PubMed ID: 33205662
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Biodegradable Polymer-biolimus-eluting Stents (BP-BES) Compared with Durable Polymer-everolimus-eluting Stents (DP-EES) in Patients Undergoing Complex Percutaneous Coronary Intervention.
Song PS; Park KT; Kim MJ; Jeon KH; Park JS; Choi RK; Song YB; Choi SH; Choi JH; Lee SH; Gwon HC; Jeong JO; Im ES; Kim SW; Chun WJ; Oh JH; Hahn JY
Korean Circ J; 2019 Jan; 49(1):69-80. PubMed ID: 30468035
[TBL] [Abstract][Full Text] [Related]
15. A propensity score-matched comparison of biodegradable polymer vs second-generation durable polymer drug-eluting stents in a real-world population.
Zhao YJ; Teng M; Khoo AL; Ananthakrishna R; Yeo TC; Lim BP; Loh JP; Chan MY
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29316284
[TBL] [Abstract][Full Text] [Related]
16. Improved clinical outcome with biodegradable polymer drug-eluting stents compared to durable polymer drug-eluting stents for primary percutaneous coronary intervention.
Andriyati R; Firman D; Kurniawati Y; Alkatiri AA; Pranata R; Muliawan HS; Rossimarina V; Soerianata S
Postgrad Med J; 2021 Oct; 97(1152):638-643. PubMed ID: 32796116
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY.
Baber U; Chandiramani R; Mehta SR; Sartori S; Zhang Z; Claessen BE; Briguori C; Sharma S; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2021 Jan; 97(1):63-71. PubMed ID: 32406998
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients treated with a biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stents after rotational atherectomy.
Mankerious N; Hemetsberger R; Traboulsi H; Toelg R; Abdel-Wahab M; Richardt G; Allali A
Clin Res Cardiol; 2021 Oct; 110(10):1574-1585. PubMed ID: 33861369
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study).
Iannaccone M; Barbero U; De Benedictis M; Imori Y; Quadri G; Trabattoni D; Ryan N; Venuti G; Montabone A; Wojakowski W; Rognoni A; Helft G; Parma R; De Luca L; Autelli M; Boccuzzi G; Mattesini A; Templin C; Cerrato E; Wańha W; Smolka G; Huczek Z; Tomassini F; Cortese B; Capodanno D; Chieffo A; Nuñez-Gil I; Gili S; Bassignana A; di Mario C; Doronzo B; Omedè P; D'Amico M; Tedeschi D; Varbella F; Luscher T; Sheiban I; Escaned J; Rinaldi M; D'Ascenzo F
BMC Cardiovasc Disord; 2020 May; 20(1):225. PubMed ID: 32414330
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials.
de Waha A; King LA; Stefanini GG; Byrne RA; Serruys PW; Meier B; Jüni P; Kastrati A; Windecker S
EuroIntervention; 2015 Apr; 10(12):1425-31. PubMed ID: 24602961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
